Leadership Team

Philip Chase

Chief Executive Officer

  • General Counsel, Alnylam Pharmaceuticals
  • General Counsel, Epix Pharmaceuticals
  • Chief Corporate Counsel, Transkaryotic Therapies (TKT)

Eric Krauland, PhD

President and Chief Scientific Officer

  • Massachusetts Institute of Technology

Ryan McGovern

Chief Financial Officer

  • Deloitte
  • Tuck School of Business at Dartmouth

Mary Schiavoni

Chief Human Resources Officer

  • Program Management, Tuck School of Business at Dartmouth
  • Human Resources, Bain & Company
  • Business Development and Sales, TD Bank Group

Guy Van Meter

Chief Business Officer

  • Business Development and Strategic Alliances, Pfizer
  • Business Development, Technology Licensing, Dyax
  • F.W. Olin Graduate School of Management at Babson

Max Vásquez, PhD

Chief Computing Officer

  • Senior Director, Research, PDL BioPharma
  • Bocaraca Consulting, Founder and President

Senior Directors

Kirt Johnson

Senior Director, Product Engineering & Operations

  • Director of Product Development, NextMark
  • Technology Development Director, King Arthur Flour Company
  • Director, Systems Architecture and Senior Architect, Applications, Affinity Internet

Juergen Nett

Senior Director, High-Throughput Expression

  • Senior Principal Scientist, Merck
  • Senior Scientist, GlycoFi
  • Dartmouth Medical School
  • University of Kaiserslautern

Robert Pejchal, PhD

Senior Director, Antibody Engineering & Protein Analytics

  • The Scripps Research Institute
  • University of Michigan - Ann Arbor

Kristin Rookey

Senior Director, Strategic Alliances

  • Principal Scientist, Dyax
  • Research Scientist, Anadys Pharmaceuticals

Founders

Tillman U. Gerngross, PhD

Co-Founder and Executive Chairman of the Board

  • Professor of Bioengineering, Dartmouth College
  • Co-Founder and CSO, GlycoFi (acquired by Merck 2006)
  • Venture Partner, SV Health Investors
  • Co-Founder, Chairman of Arsanis (merged with NASDAQ:XFOR in 2019)
  • Co-Founder, Chairman of Avitide
  • Co-Founder, Chairman of Alector (NASDAQ: ALEC)
  • Co-Founder, President, Amagma Therapeutics, Waltham, MA
  • Co-Founder, President, Ankyra Therapeutics, Boston, MA
  • Co-Founder, Adagio Therapeutics, Waltham, MA

K. Dane Wittrup, PhD

Co-Founder and Chairman of the SAB

  • Co-Founder, BioDisplay Technologies (acquired by Abbott Laboratories 2001)
  • Professor of Chemical Engineering and Bioengineering, Massachusetts Institute of Technology
  • Co-Founder of Eleven Biotherapeutics